These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 23312802)
1. Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Dillen L; Van Langenhove T; Engelborghs S; Vandenbulcke M; Sarafov S; Tournev I; Merlin C; Cras P; Vandenberghe R; De Deyn PP; Jordanova A; Cruts M; Van Broeckhoven C; van der Zee J; Neurobiol Aging; 2013 Jun; 34(6):1711.e1-5. PubMed ID: 23312802 [TBL] [Abstract][Full Text] [Related]
2. Screening UBQLN-2 in French frontotemporal lobar degeneration and frontotemporal lobar degeneration-amyotrophic lateral sclerosis patients. Lattante S; Le Ber I; Camuzat A; Pariente J; Brice A; Kabashi E; Neurobiol Aging; 2013 Aug; 34(8):2078.e5-6. PubMed ID: 23582661 [TBL] [Abstract][Full Text] [Related]
3. Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France. Lattante S; Le Ber I; Camuzat A; Brice A; Kabashi E Neurobiol Aging; 2013 Jun; 34(6):1709.e1-2. PubMed ID: 23182804 [TBL] [Abstract][Full Text] [Related]
4. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785 [TBL] [Abstract][Full Text] [Related]
5. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype. Synofzik M; Maetzler W; Grehl T; Prudlo J; Vom Hagen JM; Haack T; Rebassoo P; Munz M; Schöls L; Biskup S Neurobiol Aging; 2012 Dec; 33(12):2949.e13-7. PubMed ID: 22892309 [TBL] [Abstract][Full Text] [Related]
6. Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Van Langenhove T; van der Zee J; Engelborghs S; Vandenberghe R; Santens P; Van den Broeck M; Mattheijssens M; Peeters K; Nuytten D; Cras P; De Deyn PP; De Jonghe P; Cruts M; Van Broeckhoven C Neurobiol Aging; 2012 May; 33(5):1004.e17-20. PubMed ID: 22035589 [TBL] [Abstract][Full Text] [Related]
7. Mutation analysis and immunopathological studies of PFN1 in familial and sporadic amyotrophic lateral sclerosis. Yang S; Fifita JA; Williams KL; Warraich ST; Pamphlett R; Nicholson GA; Blair IP Neurobiol Aging; 2013 Sep; 34(9):2235.e7-10. PubMed ID: 23635659 [TBL] [Abstract][Full Text] [Related]
8. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Gijselinck I; Engelborghs S; Maes G; Cuijt I; Peeters K; Mattheijssens M; Joris G; Cras P; Martin JJ; De Deyn PP; Kumar-Singh S; Van Broeckhoven C; Cruts M Arch Neurol; 2010 May; 67(5):606-16. PubMed ID: 20457961 [TBL] [Abstract][Full Text] [Related]
9. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682 [TBL] [Abstract][Full Text] [Related]
10. Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia. van Blitterswijk M; Baker MC; Bieniek KF; Knopman DS; Josephs KA; Boeve B; Caselli R; Wszolek ZK; Petersen R; Graff-Radford NR; Boylan KB; Dickson DW; Rademakers R Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):463-9. PubMed ID: 23634771 [TBL] [Abstract][Full Text] [Related]
11. Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis. Millecamps S; Corcia P; Cazeneuve C; Boillée S; Seilhean D; Danel-Brunaud V; Vandenberghe N; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Meininger V; LeGuern E; Salachas F Neurobiol Aging; 2012 Apr; 33(4):839.e1-3. PubMed ID: 22169395 [TBL] [Abstract][Full Text] [Related]
12. UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland. McLaughlin RL; Kenna KP; Vajda A; Byrne S; Bradley DG; Hardiman O Neurobiol Aging; 2014 Jan; 35(1):267.e9-11. PubMed ID: 23973441 [TBL] [Abstract][Full Text] [Related]
13. UBQLN2 variant of unknown significance in frontotemporal lobar degeneration. Ugwu F; Rollinson S; Harris J; Gerhard A; Richardson A; Jones M; Mann D; Snowden J; Pickering-Brown S Neurobiol Aging; 2015 Jan; 36(1):546.e15-6. PubMed ID: 25179229 [TBL] [Abstract][Full Text] [Related]
14. A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Ingre C; Landers JE; Rizik N; Volk AE; Akimoto C; Birve A; Hübers A; Keagle PJ; Piotrowska K; Press R; Andersen PM; Ludolph AC; Weishaupt JH Neurobiol Aging; 2013 Jun; 34(6):1708.e1-6. PubMed ID: 23141414 [TBL] [Abstract][Full Text] [Related]
15. Genetic contribution of FUS to frontotemporal lobar degeneration. Van Langenhove T; van der Zee J; Sleegers K; Engelborghs S; Vandenberghe R; Gijselinck I; Van den Broeck M; Mattheijssens M; Peeters K; De Deyn PP; Cruts M; Van Broeckhoven C Neurology; 2010 Feb; 74(5):366-71. PubMed ID: 20124201 [TBL] [Abstract][Full Text] [Related]
16. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Williams KL; Warraich ST; Yang S; Solski JA; Fernando R; Rouleau GA; Nicholson GA; Blair IP Neurobiol Aging; 2012 Oct; 33(10):2527.e3-10. PubMed ID: 22717235 [TBL] [Abstract][Full Text] [Related]
17. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. Broustal O; Camuzat A; Guillot-Noël L; Guy N; Millecamps S; Deffond D; Lacomblez L; Golfier V; Hannequin D; Salachas F; Camu W; Didic M; Dubois B; Meininger V; Le Ber I; Brice A; J Alzheimers Dis; 2010; 22(3):765-9. PubMed ID: 21158017 [TBL] [Abstract][Full Text] [Related]
19. UBQLN2 in familial amyotrophic lateral sclerosis in The Netherlands. van Doormaal PT; van Rheenen W; van Blitterswijk M; Schellevis RD; Schelhaas HJ; de Visser M; van der Kooi AJ; Veldink JH; van den Berg LH Neurobiol Aging; 2012 Sep; 33(9):2233.e7-2233.e8. PubMed ID: 22676852 [TBL] [Abstract][Full Text] [Related]
20. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis. Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]